Table 3. Investigation of the efficacy of Pitavastatin and Atorvastatin on 207 dyslipidemia patients with impaired glucose tolerance (ref 24).
Week 8 | Week 28 | Week 56 | |
---|---|---|---|
Pitavastatin | 98% (86/88) | 94% (83/88) | 93% (79/85) |
Atorvastatin | 100% (84/84) | 96% (81/84) | 98% (80/82) |